Charles Schwab Investment Advisory’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,369,629
Closed -$232M 70
2019
Q4
$232M Buy
3,369,629
+181,933
+6% +$12.4M 0.33% 87
2019
Q3
$234M Buy
3,187,696
+118,934
+4% +$8.63M 0.36% 85
2019
Q2
$220M Buy
3,068,762
+97,521
+3% +$6.92M 0.35% 84
2019
Q1
$204M Buy
2,971,241
+136,505
+5% +$8.82M 0.34% 85
2018
Q4
$169M Buy
2,834,736
+76,853
+3% +$4.81M 0.32% 92
2018
Q3
$185M Buy
2,757,883
+75,398
+3% +$5.02M 0.32% 89
2018
Q2
$174M Buy
+2,682,485
New +$175M 0.32% 88

Other funds holding CL

Charles Schwab Investment Advisory's CL Position: Q1 2020 in Review

Charles Schwab Investment Advisory sold out of Colgate-Palmolive (CL) in Q1 2020, closing a stake of 3,369,629 shares — an estimated $232M sold.

Charles Schwab Investment Advisory first reported a position in CL in Q2 2018 and held it in 7 quarters. The position peaked at $234M in Q3 2019. 1,493 funds tracked by Wall St. Rank hold CL as of Q1 2020.

  • Charles Schwab Investment Advisory reported no remaining Colgate-Palmolive position as of Q1 2020 after selling out during the quarter.
  • Charles Schwab Investment Advisory sold 3,369,629 Colgate-Palmolive shares in Q1 2020, an estimated $232M.
  • Charles Schwab Investment Advisory first reported a position in Colgate-Palmolive in Q2 2018 and held it in 7 quarters.
  • Charles Schwab Investment Advisory's Colgate-Palmolive position peaked at $234M in Q3 2019.
  • 1,493 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2020.

Based on Charles Schwab Investment Advisory's 13F filing for Q1 2020, filed 15 May 2020.